Previous 10 | Next 10 |
2024-03-05 06:15:00 ET The gold rush for anti-obesity medicines is here, and the stakes are high. Per a report by Morgan Stanley Research, the market for weight loss drugs will be worth around $77 billion by 2030, despite being worth only $2.4 billion in 2022. Where should investors...
Viking Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares PR Newswire SAN DIEGO , March 4, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a cli...
2024-03-04 05:58:00 ET With shares of Viking Therapeutics (NASDAQ: VKTX) flying 555% higher in the last three months, at least one financial analyst is saying that it can go even higher. On Feb. 28, Oppenheimer 's Jay Olsen adjusted his price target from $46 to $116, which impli...
2024-03-03 09:35:00 ET Comparing Eli Lilly (NYSE: LLY) and Viking Therapeutics (NASDAQ: VKTX) might initially seem odd. The two drugmakers don't seem to have much in common. Eli Lilly is more than 50 times the size of Viking by market cap and boasts a long list of approved m...
2024-03-03 07:41:00 ET After rising by 137% in one day upon the publication of favorable phase 2 clinical trial results on Feb. 27, Viking Therapeutics (NASDAQ: VKTX) is now doubtlessly on many investors' radars. Soon enough, the biotech will likely try to launch a new weight loss m...
2024-03-01 07:31:00 ET Technically, there is no upper limit to how much money investors can make from stocks in five years, but turning $1,000 into $2,500 is no easy task. That requires a compound annual growth rate (CAGR) of 20.1%, more than double the S&P 500's historical growth rate....
2024-02-29 07:45:00 ET On Tuesday, Viking Therapeutics (NASDAQ: VKTX) , a clinical-stage biotech specializing in treatments for metabolic diseases, saw its stock price surge by a staggering 121% in response to a clinical update for its mid-stage obesity candidate, VK2735. Over the p...
2024-02-29 06:42:00 ET The weight loss drug market is growing in leaps and bounds -- and today the biggest winners are Eli Lilly and Novo Nordisk . These big pharma companies are bringing in billions thanks to their drugs that are helping those suffering from obesity shed pounds fas...
2024-02-29 04:53:00 ET Shares of Viking Therapeutics (NASDAQ: VKTX) , a clinical-stage biotech, more than doubled recently. The market started hurling money at the stock after some mid-stage clinical trial results suggested a bright future for its still-experimental weight managemen...
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock PR Newswire SAN DIEGO , Feb. 28, 2024 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (Nasdaq: VKTX), a clinical-stage biopharmaceutical company focused on the development ...
News, Short Squeeze, Breakout and More Instantly...
Viking Therapeutics Inc. Company Name:
VKTX Stock Symbol:
NASDAQ Market:
Viking Therapeutics Inc. Website:
2024-07-20 06:00:00 ET California's giant redwood trees were once tiny sprouts or seeds. Likewise, the world's biggest companies were once much smaller. Trees and companies can grow significantly over time -- at least some of them. Three Motley Fool contributors think they've found bi...
2024-07-19 05:50:00 ET Fortunes have been made on biotech stocks over the last few decades. The secret to success has been to invest in an up-and-coming biotech company before it even had a product on the market. Ideally, the company would have a pipeline featuring multiple promising candid...
Viking Therapeutics to Report Financial Results for Second Quarter 2024 on July 24, 2024 PR Newswire Conference Call Scheduled for Wednesday, July 24 at 4:30 p.m. Eastern Time SAN DIEGO , July 17, 2024 /PRNewswire/ -- Viking Therapeutics, Inc...